387 related articles for article (PubMed ID: 36206585)
1. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
[TBL] [Abstract][Full Text] [Related]
2. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
Faller RW; Erausquin JT; McCoy TP
Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
[No Abstract] [Full Text] [Related]
3. National polydrug use patterns among people who misuse prescription opioids and people who use heroin. Results from the National Household Survey on Drug Use and Health.
Bobashev GV; Warren LK
Drug Alcohol Depend; 2022 Sep; 238():109553. PubMed ID: 35905594
[TBL] [Abstract][Full Text] [Related]
4. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study.
Hudgins JD; Porter JJ; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002922. PubMed ID: 31689290
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Use/Misuse of Specific Illicit and Prescription Drugs among Sexual Minority Adults in a National Sample.
Schuler MS; Collins RL; Ramchand R
Subst Use Misuse; 2022; 57(3):461-471. PubMed ID: 35067155
[No Abstract] [Full Text] [Related]
6. The epidemiology of prescription fentanyl misuse in the United States.
Schepis TS; McCabe VV; Boyd CJ; McCabe SE
Addict Behav; 2019 Sep; 96():89-93. PubMed ID: 31063940
[TBL] [Abstract][Full Text] [Related]
7. Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019.
O'Donnell J; Gladden RM; Mattson CL; Hunter CT; Davis NL
MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1189-1197. PubMed ID: 32881854
[TBL] [Abstract][Full Text] [Related]
8. Nonmedical use of prescription opioids and stimulants among student pharmacists.
Lord S; Downs G; Furtaw P; Chaudhuri A; Silverstein A; Gammaitoni A; Budman S
J Am Pharm Assoc (2003); 2009; 49(4):519-28. PubMed ID: 19589764
[TBL] [Abstract][Full Text] [Related]
9. Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
McCabe SE; Figueroa O; McCabe VV; Schepis TS; Schulenberg JE; Veliz PT; Werner KS; Wilens TE
J Child Psychol Psychiatry; 2024 Jan; 65(1):100-111. PubMed ID: 37062713
[TBL] [Abstract][Full Text] [Related]
10. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
11. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
12. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence.
McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
[TBL] [Abstract][Full Text] [Related]
14. Stimulant misuse among youth.
LaBossier NJ; Hadland SE
Curr Probl Pediatr Adolesc Health Care; 2022 Sep; 52(9):101265. PubMed ID: 36184490
[TBL] [Abstract][Full Text] [Related]
15. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
Beliveau CM; McMahan VM; Arenander J; Angst MS; Kushel M; Torres A; Santos GM; Coffin PO
Subst Abus; 2022; 43(1):179-186. PubMed ID: 33798030
[TBL] [Abstract][Full Text] [Related]
16. Are prescription misuse and illicit drug use etiologically distinct? A genetically-informed analysis of opioids and stimulants.
Dash GF; Martin NG; Agrawal A; Lynskey MT; Slutske WS
Psychol Med; 2022 Oct; 52(14):3176-3183. PubMed ID: 33455586
[TBL] [Abstract][Full Text] [Related]
17. Unmet Need in Relation to Mental Healthcare and Past-Month Drug Use among People with Mental Illness in the United States.
Reid BE; Palamar JJ
J Psychoactive Drugs; 2022; 54(3):241-249. PubMed ID: 34402414
[TBL] [Abstract][Full Text] [Related]
18. Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.
Foot C; Korthuis PT; Tsui JI; Luo SX; Chan B; Cook RR
Addiction; 2024 Jan; 119(1):149-157. PubMed ID: 37712113
[TBL] [Abstract][Full Text] [Related]
19. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.
Han BH; Sherman SE; Palamar JJ
Prev Med; 2019 Apr; 121():94-98. PubMed ID: 30763631
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in the prevalence of stimulant misuse in the United States: 2015-2019.
McHugh RK; Korte FM; Bichon JA; Weiss RD
Am J Addict; 2024 May; 33(3):283-289. PubMed ID: 37924248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
